-
ARVO 2024 Highlight: Positive Two-Year Results from PDE6B Gene Therapy Clinical Trial
Eye On the Cure Research News -
Beacon Stories
-
Eye on the Cure Podcast | Episode 65: Matthew Whitaker
Foundation Podcasts
-
Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
Eye On the Cure Research News -
SalioGen Developing Novel Gene Insertion Therapy for Stargardt Disease
Eye On the Cure Research News
Our Impact
The Foundation is committed to finding treatments and cures for people affected by blinding retinal diseases.
-
1st gene therapy
for any inherited disease to be approved by the FDA
learn more -
$915M+ dollars raised
since 1971
learn more -
35 VisionWalk events
throughout the United States
learn more -
93 grants awarded
in 2023 – over 96 investigators, 71 institutions
Learn more
The Foundation in the News
ARVO 2024 Highlight: New Gene Linked to RP in People with African Ancestry
Eye On the Cure Research News-
May 10, 2024
ARVO 2024 Highlight: Positive Two-Year Results from PDE6B Gene Therapy Clinical Trial
Eye On the Cure Research News -
May 6, 2024Beacon Stories
-
May 2, 2024
Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
Eye On the Cure Research News
Living with vision loss can be difficult, but you don't have to do it alone
View local chaptersGet Involved
-
Take important steps toward a cure by participating in a 5k VisionWalk
Join a Walk -
Join people coming together to find a cure from all over the country
Search Our Events -
Make a difference today and support promising research by donating a one-time gift
Donate Now